Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Bayer to acquire AskBio for up to $4B

By Brian Buntz | October 26, 2020

 Bayer (FRA: BAYN) announced today that it will acquire gene therapy startup AskBio for an upfront payment of $2 billion.

The German life sciences giant could shell out an additional $2 billion if the startup meets specific criteria.

Rather than folding AskBio’s operations into its own, Bayer stressed in a statement that the startup would operate independently “on an arm’s length basis.”

The acquisition could be a boon for Bayer’s drug pipeline as lawsuits and COVID-19 have caused its stock to tumble in 2020. Since the beginning of the year, the company’s stock has fallen more than 40%. 

In particular, AskBio could bolster Bayer’s cell and gene therapy portfolio. The startup already has an Adeno-associated virus (AAV)–based gene therapy platform on the market. Bayer plans to tap its development and manufacturing capabilities to expand AskBio’s AAV therapeutic offerings. 

The acquisition of AskBio, whose name is an abbreviation of Asklepios BioPharmaceutical Inc., is the largest for Bayer since its purchase of Schering AG in 2006 for €14.6 billion. 

In January, Bayer announced a collaboration with Exscientia on AI-based drug discovery.


Filed Under: Drug Discovery, Drug Discovery and Development
Tagged With: AskBio, Bayer
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

EpicentRx
A next-gen vaccine that could help end COVID-19 whack-a-mole 
Dotmatics
How Dotmatics aims to help reduce the drug discovery failure rate
Diversity
Making diversity in clinical research more than a talking point
psychedelic medicine discussed at SXSW
5 headwinds and 5 tailwinds for psychedelic medicine

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Medtech100 Index
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50